ArticleAntonie van Leeuwenhoek2026
Scorpion gut microbiomes as a source of bioactive and rare actinobacteria with nonribosomal peptide potential.
Article in Antonie van Leeuwenhoek, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Actinobacteria are well-known for their ability to produce bioactive secondary metabolites, including nonribosomal peptides (NRPs); however, many host-associated reservoirs remain underexplored. In this study, cultivable actinobacteria were isolated from scorpion gut, including both the intestinal tissue and its luminal contents, and evaluated their antimicrobial activity and presence of NRPs genes. Fifty scorpions (Odontobuthus doriae and Mesobuthus eupeus) were collected from Qom Province, Iran. Dissected gut homogenates were plated on selective media, yielding 120 pure isolates. Taxonomic identification was performed by 16S rRNA gene sequencing, antimicrobial activity was assessed using agar diffusion assays against a broad panel of bacteria and fungi, and isolates were screened for NRPS gene biosynthetic markers by PCR (using A3F/A7R primers). The collection was dominated by Streptomyces, with additional recovery of rarer genera such as Amycolatopsis and Nonomuraea. Overall, 57% of the isolates inhibited at least one test microorganisms, and some strains exhibited specific bioactivity, making them candidates for further investigation. NRPS amplicons (~ 700 bp) were detected in 33.3% of the isolates and were enriched among the 42.6% of bioactive isolates, suggesting a partial association between antimicrobial phenotypes and putative NRP biosynthetic capacity. Five isolates showed < 98.5% 16S rRNA similarity to described species, indicating potential taxonomic novelty. Collectively, these findings support scorpion guts as promising, niche-derived sources of diverse actinobacteria with antimicrobial activity and biosynthetic potential for natural product discovery.
Indexed as
Identifiers
42177354What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.